CLINICAL_TRIALS
trial_result
· 2021-02-15
Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia [Phase 2]
Summary
A Phase 2 study evaluating AMG531 in patients with aplastic anemia has completed with results posted in February 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Korea Co., Ltd. | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-15